Home - Products - Others - Other Targets - APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)

APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)

CAS No. 1233876-42-0

APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)( ——— )

Catalog No. M40887 CAS No. 1233876-42-0

APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
  • Note
    Research use only, not for human use.
  • Brief Description
    APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
  • Description
    APL1β28 trifluoroacetate salt/APLP1-derived Aβ-like peptide (1-28)
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    1233876-42-0
  • Formula Weight
    2585.92
  • Molecular Formula
    C105H185N31O39S1
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 1-Phenylethanol

    1-Phenylethanol has a nongenotoxic mode of action responsible for the lung and liver tumors observed in mice following 2 years of inhalation exposure to ethylbenzene.

  • Chaetocin

    Chaetocin, a natural product from Chaetomium species, is a histone methyltransferase inhibitor with IC50 of 0.8 μM, 2.5 μM and 3 μM for dSU(VAR)3-9, mouse G9a and Neurospora crassa DIM5, respectively.

  • Pivagabine

    Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.